复星衍生物的最新进展:结构变化和生物活动
Xiaohan Liu1, Jian Pei1, Jiahui Li1
1School of Biology, Food and Environment, Hefei University, Hefei 230601, China.
Molecules (Basel, Switzerland)
|February 26, 2025
概括
复星衍生物通过增强药理活性和药物可用性,显示出更好的治疗潜力. 本综述探讨了它们的生物活动和结构-活性关系,以发现新的药物.
科学领域:
- 自然产品化学 自然产品化学
- 药品化学 药品化学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 复星是一种天然的多,具有多种生物活性,包括抗炎,抗癌,抗氧化,抗菌和神经保护作用.
- 由于吸收不良和潜在的肝毒性,resveratrol的直接治疗应用受到限制.
- 最近的研究重点是修改复星的结构以克服这些局限性.
研究的目的:
- 审查复星衍生物的生物活性.
- 分析这些衍生品的结构-活动关系 (SARs).
- 为开发基于白醇的新疗法提供见解.
主要方法:
- 在过去五年中发表的关于复星衍生物的文献综述.
- 对报告的生物活性进行分析 (例如,抗炎,抗癌,抗氧化,抗菌,神经保护).
- 检查SAR数据以将结构修改与药理学结果相关联.
主要成果:
- 与原始化合物相比,许多复星衍生物已经显示出增强的药理活性.
- 结构性修改导致药物可用性和生物可用性的显著改善.
- 已经确定了特定的SAR,指导了具有更好的疗效和安全性配置文件的衍生品的设计.
结论:
- 复星衍生物代表了治疗开发的有希望的途径,克服了原生复星的局限性.
- 了解SAR对于合理设计下一代基于白醇的药物至关重要.
- 对新型白醇衍生物的进一步研究有可能用于治疗各种疾病.
更多相关视频
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
218
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.0K
相关概念视频
Structure-Activity Relationships and Drug Design
483
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
483
Prodrugs
2.4K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.4K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.5K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
G Protein-coupled Receptors
11.1K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.1K
